Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_assertion type Assertion NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_head.
- NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_assertion wasGeneratedBy ECO_0000203 NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_provenance.
- NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_assertion wasDerivedFrom gad-20150221 NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_provenance.
- NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_assertion SIO_000772 19698125 NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_provenance.
- NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_assertion evidence source_evidence_literature NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_provenance.
- NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_assertion description "[Furthermore, HLA-DRB1*1601 (9.0% vs. 1.8%; P = 0.0016; OR = 5.81; CI = 2.05-16.46) was associated with susceptibility to borderline leprosy compared to control group, and while HLA-DRB1*08 (11.2% vs. 1.2%; P = 0.0037; OR = 12.00; CI = 1.51 - 95.12) was associated with susceptibility to lepromatous leprosy, when compared to tuberculoid leprosy, DRB1*04 was associated to protection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103295.RAZ7EIqVZtB4hA3OblSlZ4naTDpcgaPLQSrBCbc38SqdA130_provenance.